Hand Held Products, Inc.

Hainan Hdeton Science and Technology Co., Ltd.

Meridian Laboratories, Inc.

Jianfeng Gao

Yong Ren

Ling Wu

Shuqin Yu

Jerry Wu

Lin Wang

Zhongqi Liu

Jian Li

Hong Jian Jin

Hongfeng Huang

Yunsheng Pi

Zhengyang Xie

HongJian Jin

A wireless scanner is described that performs a pairing operation with a wireless scanner base before commencing scanning operations in a wireless scanner network. Radio frequency identification (RFID) is used to achieve the pairing operation of the wireless scanner with the wireless scanner base by using an RFID tag associated with the wireless scanner base. The RFID tag in the wireless scanner base may contain pairing information such as a network address of the wireless scanner base for use in automatically establishing a wireless communication session with the wireless scanner base in accordance with another wireless protocol.

Pairing method for wireless scanner via RFID

A cordless indicia reader including a multifunction coil that can be configured to either transmit or receive electromagnetic energy is disclosed. In this way, the multifunction coil facilitates both the wireless charging of a battery and the wireless deactivation of electronic article surveillance (EAS) tags. The multifunction coil and a plurality of modules to perform these functions are integrated within the cordless indicia reader's hand-supportable housing.

Cordless indicia reader with a multifunction coil for wireless charging and EAS deactivation

A cordless indicia reader including a multifunction coil that can be configured to either transmit or receive electromagnetic energy is disclosed. In this way, the multifunction coil facilitates both the wireless charging of a battery and the wireless deactivation of electronic article surveillance (EAS) tags. The multifunction coil, and a plurality of modules to perform these functions, are integrated within the cordless indicia reader's hand-supportable housing.

A docetaxel inclusion complex having improved water-solubility (up to 15 mg/ml) and stability (stability constant Ka=2056 M-13051 M), comprises docetaxel and hydroxypropyl-beta-cyclodextrin and/or sulfobutyl-beta-cyclodextrin in a ratio of 1:10-150. The method includes steps as follows: docetaxel dissolved in ethanol is added into water solution of cyclodextrin via stirring, until docetaxel is completely dissolved; said solution is filtered in 0.2-04 &#x3bc;m microporous membrane then ethanol is removed through reduced pressure to obtain the inclusion complex in a liquid form; or ethanol, followed by water is removed through reduced pressure, then dried to obtain the inclusion complex in a solid form.

Pharmaceutical composition containing docetaxel-cyclodextrin inclusion complex and its preparing process

A docetaxel inclusion complex having improved water-solubility (up to 15 mg/ml) and stability (stability constant Ka=2056M-13051M), comprises docetaxel and hydroxypropyl-beta-cyclodextrin and/or sulfobutyl-beta-cyclodextrin in a ratio of 1:10-150. The method includes steps as follows: docetaxel dissolved in ethanol is added into water solution of cyclodextrin via stirring, until docetaxel is completely dissolved; said solution is filtered in 0.2-04 &#x3bc;m microporous membrane then ethanol is removed through reduced pressure to obtain the inclusion complex in a liquid form; or ethanol, followed by water is removed through reduced pressure, then dried to obtain the inclusion complex in a solid form.

A pharmaceutical composition comprising cyclodextrin/paclitaxel inclusion, which consists of paclitaxel, cyclodextrin and a pharmaceutically acceptable excipient, wherein the mass ratio of the paclitaxel to cyclodextrin is 1:10-150, the said cyclodextrin is hydroxylpropyl-sulfobutyl-7-&#x3b2;-cyclodextrin, or sulfobutylether-7-&#x3b2;-cyclodextrin, or their mixture; the stability constant of the cyclodextrin/paclitaxel inclusion is Ka=5396M&#x2212;1&#x2212;1412M&#x2212;1. The preparation method of the pharmaceutical composition is as follow: (a) A solution of cyclodextrin is added dropwise to a solution of paclitaxel in ethanol. (b) The resulting mixture is filtered through microporous membrane of 0.2-0.4 &#x3bc;m after being dissolved. (c) Ethanol is removed under reduced pressure to give a liquid inclusion which has the ethanol level of less than 2%, or alternatively water is also removed under reduced pressure, the resulting product is dried giving a solid inclusion.

Growing community of inventors

Jiangsu, China

Jianfeng Gao